$345 Million is the total value of Monashee Investment Management LLC's 38 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 63.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | HYPERFINE INC | $6,213,000 | -60.5% | 1,755,038 | -19.2% | 1.80% | -53.8% | |
| FULC | Sell | FULCRUM THERAPEUTICS INC | $5,600,000 | +15.9% | 236,991 | -13.2% | 1.62% | +35.8% |
| Sell | CARIBOU BIOSCIENCES INC | $4,315,000 | -43.3% | 470,000 | -6.8% | 1.25% | -33.5% | |
| Sell | SOMALOGIC INC | $4,090,000 | -57.7% | 510,000 | -38.6% | 1.18% | -50.4% | |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $3,893,000 | -1.9% | 264,111 | -12.0% | 1.13% | +14.9% |
| Sell | DOCGO INC | $3,787,000 | -46.0% | 409,431 | -45.4% | 1.10% | -36.7% | |
| MYPS | Sell | PLAYSTUDIOS INC | $3,386,000 | -14.3% | 699,503 | -30.0% | 0.98% | +0.5% |
| Sell | ELIEM THERAPEUTICS INC | $1,906,000 | -39.3% | 227,201 | -24.3% | 0.55% | -28.9% | |
| CMPX | Sell | COMPASS THERAPEUTICS INC | $1,740,000 | -72.6% | 1,270,211 | -36.5% | 0.50% | -67.8% |
| KDNY | Sell | CHINOOK THERAPEUTICS INC | $1,472,000 | -5.0% | 90,000 | -5.3% | 0.43% | +11.2% |
| Sell | XILIO THERAPEUTICS INC | $1,153,000 | -66.4% | 163,066 | -23.9% | 0.33% | -60.6% | |
| Sell | PARDES BIOSCIENCES INC | $1,142,000 | -86.0% | 158,196 | -68.4% | 0.33% | -83.6% | |
| Sell | OMEGA THERAPEUTICS INC | $771,000 | -84.6% | 123,614 | -72.0% | 0.22% | -82.0% | |
| Sell | THORNE HEALTHTECH INC | $708,000 | -46.0% | 111,250 | -47.3% | 0.20% | -36.7% | |
| Sell | AFTERNEXT HEALTHTECH ACQUISI*w exp 99/99/999 | $21,000 | -55.3% | 50,318 | -24.5% | 0.01% | -50.0% | |
| UPHWS | Exit | UPHEALTH IN - CW24*w exp 06/08/202 | $0 | – | -49,997 | -100.0% | -0.00% | – |
| Exit | PERION NETWORK LTD | $0 | – | -20,000 | -100.0% | -0.12% | – | |
| VRAY | Exit | VIEWRAY INC | $0 | – | -100,000 | -100.0% | -0.14% | – |
| FREEW | Exit | WHOLE EARTH BRANDS INC*w exp 06/25/202 | $0 | – | -561,440 | -100.0% | -0.16% | – |
| Exit | SAMSARA INC-CL A | $0 | – | -30,000 | -100.0% | -0.21% | – | |
| Exit | BETTER THERAPEUTICS INC | $0 | – | -217,900 | -100.0% | -0.25% | – | |
| LEGN | Exit | LEGEND BIOTECH CORP-ADRsponsored ads | $0 | – | -30,000 | -100.0% | -0.35% | – |
| Exit | SOLO BRANDS INC - CLASS A | $0 | – | -90,000 | -100.0% | -0.35% | – | |
| STWD | Exit | STARWOOD PROPERTY TRUST INC | $0 | – | -75,000 | -100.0% | -0.45% | – |
| Exit | NU HOLDINGS LTD/CAYMAN ISL-A | $0 | – | -200,000 | -100.0% | -0.46% | – | |
| BLU | Exit | BELLUS HEALTH INC | $0 | – | -250,000 | -100.0% | -0.50% | – |
| Exit | HASHICORP INC-CL A | $0 | – | -22,750 | -100.0% | -0.51% | – | |
| Exit | SURROZEN INC | $0 | – | -350,000 | -100.0% | -0.56% | – | |
| SI | Exit | SILVERGATE CAPITAL CORP-CL Acl a | $0 | – | -16,000 | -100.0% | -0.59% | – |
| Exit | LOCAL BOUNTI CORP | $0 | – | -400,000 | -100.0% | -0.64% | – | |
| Exit | HUMACYTE INC | $0 | – | -399,910 | -100.0% | -0.72% | – | |
| HAIN | Exit | HAIN CELESTIAL GROUP INC | $0 | – | -72,507 | -100.0% | -0.76% | – |
| OWL | Exit | BLUE OWL CAPITAL INC | $0 | – | -220,000 | -100.0% | -0.81% | – |
| FOCS | Exit | FOCUS FINANCIAL PARTNERS-A | $0 | – | -55,000 | -100.0% | -0.81% | – |
| PCPC | Exit | PERIPHAS CAPITAL PARTNR-CL A | $0 | – | -146,222 | -100.0% | -0.88% | – |
| Exit | BOWLERO CORP | $0 | – | -450,000 | -100.0% | -1.00% | – | |
| UP | Exit | WHEELS UP EXPERIENCE INC | $0 | – | -922,461 | -100.0% | -1.06% | – |
| SOFI | Exit | SOFI TECHNOLOGIES INC | $0 | – | -300,000 | -100.0% | -1.17% | – |
| NTRA | Exit | NATERA INC | $0 | – | -55,000 | -100.0% | -1.27% | – |
| FHTX | Exit | FOGHORN THERAPEUTICS INC | $0 | – | -240,000 | -100.0% | -1.36% | – |
| ADC | Exit | AGREE REALTY CORP | $0 | – | -125,000 | -100.0% | -2.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CIDARA THERAPEUTICS INC | 16 | Q3 2023 | 1.3% |
| VANGUARD TOTAL STOCK MKT ETF | 12 | Q2 2023 | 82.1% |
| SOMALOGIC INC | 9 | Q3 2023 | 3.4% |
| BIONANO GENOMICS INC | 9 | Q4 2020 | 0.1% |
| COMPASS THERAPEUTICS INC | 8 | Q3 2023 | 4.8% |
| BIOMX INC | 8 | Q3 2021 | 0.0% |
| AN2 THERAPEUTICS INC | 7 | Q3 2023 | 1.9% |
| COLLIER CREEK HOLDINGS | 7 | Q2 2020 | 0.3% |
| WHOLE EARTH BRANDS INC | 7 | Q4 2021 | 0.2% |
| FINTECH ACQUISITION CORP III | 7 | Q3 2020 | 0.2% |
View Monashee Investment Management LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-07 |
View Monashee Investment Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.